About The Study: This analysis found that the COVID-19 pandemic was associated with shifts in the focus of payments from pharmaceutical and medical device companies to physicians and teaching hospitals for research and an immediate and sustained decline in payments for marketing. Research payments were stable during the pandemic despite widespread clinical trial suspensions, which may reflect clinical trial adaptations, including virtual study visits and remote outcome measurement.
Authors: Timothy S. Anderson, M.D., M.A.S., of Harvard Medical School in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2022.3342)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.3342?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=093022
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
Journal
JAMA Health Forum